Philochem is happy to announce the start of an Innosuisse collaboration with the Department of Neurology at the University Hospital and University of Zurich. During the collaboration, both teams will explore the usage of novel Immunocytokines for the treatment of brain tumors in preclinical mouse models facilitating the development of novel brain tumor therapies.